4
Changes in Ownership
Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-16-137782
Chief Executive Officer acquired 20,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Cohen Yuval · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-08-17 | Exercise or conversion : show line 1 in the form | +20,000 | $1.00 | $20,000 | 31,490 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|
| 2016-08-17 | Exercise or conversion : show line 2 in the form Options to purchase common stock | −20,000 | $1.00 | $20,000 | $1.00 | 2024-04-11 | 20,000 | 292,728 | D |
Loading xslF345X03/doc4.xml…